{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T12:02:22Z","timestamp":1794312142672,"version":"4.9.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.vaccine.2009.01.116","type":"journal-article","created":{"date-parts":[[2009,2,3]],"date-time":"2009-02-03T09:56:50Z","timestamp":1233655010000},"page":"1889-1897","source":"Crossref","is-referenced-by-count":131,"title":["A phase I clinical trial of a PER.C6\u00ae cell grown influenza H7 virus vaccine"],"prefix":"10.1016","volume":"27","author":[{"given":"Rebecca J.","family":"Cox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah S.","family":"Madhun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solveig","family":"Hauge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haakon","family":"Sjursen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Major","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam","family":"Kuhne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"H\u00f6schler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Saville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick R.","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Barclay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Donatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Zambon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars R.","family":"Haaheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"March (1)","key":"10.1016\/j.vaccine.2009.01.116_bib1","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1128\/mr.56.1.152-179.1992","article-title":"Evolution and ecology of influenza A viruses","volume":"56","author":"Webster","year":"1992","journal-title":"Microbiol Rev"},{"key":"10.1016\/j.vaccine.2009.01.116_bib2","unstructured":"World Health Organization. Cumulative Number of Confirmed Human Cases of Avian Influenza A\/(H5N1) Reported to WHO. 2009 [cited 2009]; Available from: <http:\/\/www.who.int\/csr\/disease\/avian_influenza\/country\/cases_table_2009_01_14\/en\/index.html>."},{"key":"10.1016\/j.vaccine.2009.01.116_bib3","unstructured":"HPA Press Statement. Confirmation of Avian Influenza H7N2 Infection. 2007 [cited 2007 25 May]; Available from: <http:\/\/www.hpa.org.uk\/hpa\/news\/articles\/press_releases\/2007\/070525_avian_flu_H7N2.htm>."},{"issue":"December (12)","key":"10.1016\/j.vaccine.2009.01.116_bib4","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.3201\/eid1012.040961","article-title":"Human illness from avian influenza H7N3, British Columbia","volume":"10","author":"Tweed","year":"2004","journal-title":"Emerg Infect Dis"},{"issue":"February (5)","key":"10.1016\/j.vaccine.2009.01.116_bib5","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1073\/pnas.0308352100","article-title":"Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome","volume":"101","author":"Fouchier","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"September (9031)","key":"10.1016\/j.vaccine.2009.01.116_bib6","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0140-6736(05)64783-6","article-title":"Avian influenza virus isolated from a woman with conjunctivitis","volume":"348","author":"Kurtz","year":"1996","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2009.01.116_bib7","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s007050050329","article-title":"Characterisation of an avian influenza A virus isolated from a human\u2014is an intermediate host necessary for the emergence of pandemic influenza viruses?","volume":"143","author":"Banks","year":"1998","journal-title":"Arch Virol"},{"issue":"February (9409)","key":"10.1016\/j.vaccine.2009.01.116_bib8","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0140-6736(04)15589-X","article-title":"Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands","volume":"363","author":"Koopmans","year":"2004","journal-title":"Lancet"},{"issue":"May (21)","key":"10.1016\/j.vaccine.2009.01.116_bib9","doi-asserted-by":"crossref","first-page":"7558","DOI":"10.1073\/pnas.0801259105","article-title":"Contemporary North American influenza H7 viruses possess human receptor specificity: implications for virus transmissibility","volume":"105","author":"Belser","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"March (13)","key":"10.1016\/j.vaccine.2009.01.116_bib10","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa055778","article-title":"Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine","volume":"354","author":"Treanor","year":"2006","journal-title":"N Engl J Med"},{"issue":"December (3\u20134)","key":"10.1016\/j.vaccine.2009.01.116_bib11","first-page":"203","article-title":"Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines","volume":"191","author":"Hehme","year":"2002","journal-title":"Med Microbiol Immunol (Berl)"},{"issue":"June (9272)","key":"10.1016\/j.vaccine.2009.01.116_bib12","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/S0140-6736(00)05066-2","article-title":"Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A\/Duck\/Singapore\/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza","volume":"357","author":"Nicholson","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2009.01.116_bib13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1750-2659.2006.00003.x","article-title":"Reference viruses for seasonal and pandemic influenza vaccine preparation","volume":"1","author":"Wood","year":"2007","journal-title":"Influenza Other Respir Viruses"},{"issue":"3","key":"10.1016\/j.vaccine.2009.01.116_bib14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1750-2659.2007.00015.x","article-title":"Preparation of genetically engineered A\/H5N1 and A\/H7N1 pandemic vaccine viruses by reverse genetics in a mixture of Vero and chicken embryo cells","volume":"1","author":"Legastelois","year":"2007","journal-title":"Influenza Other Respir Viruses"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2009.01.116_bib15","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1128\/CVI.00174-07","article-title":"Development and evaluation of an influenza virus subtype H7N2 vaccine candidate for pandemic preparedness","volume":"14","author":"Pappas","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"March (14)","key":"10.1016\/j.vaccine.2009.01.116_bib16","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.vaccine.2008.01.036","article-title":"Development of Eurasian H7N7\/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine","volume":"26","author":"Jadhao","year":"2008","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2009.01.116_bib17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1750-2659.2007.00022.x","article-title":"Generation of candidate human influenza vaccine strains in cell culture\u2014rehearsing the European response to an H7N1 pandemic threat","volume":"1","author":"Whiteley","year":"2007","journal-title":"Influenza Other Respir Viruses"},{"issue":"April (22)","key":"10.1016\/j.vaccine.2009.01.116_bib18","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1016\/j.vaccine.2004.08.054","article-title":"Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system","volume":"23","author":"Nicolson","year":"2005","journal-title":"Vaccine"},{"issue":"August (25\u201326)","key":"10.1016\/j.vaccine.2009.01.116_bib19","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1016\/S0264-410X(02)00268-2","article-title":"Eight-plasmid system for rapid generation of influenza virus vaccines","volume":"20","author":"Hoffmann","year":"2002","journal-title":"Vaccine"},{"issue":"August (Suppl 1)","key":"10.1016\/j.vaccine.2009.01.116_bib20","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1086\/514169","article-title":"Immunogenicity and reactogenicity of influenza subunit vaccines produced in MDCK cells or fertilized chicken eggs","volume":"176","author":"Palache","year":"1997","journal-title":"J Infect Dis"},{"issue":"June (24)","key":"10.1016\/j.vaccine.2009.01.116_bib21","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1056\/NEJMoa073121","article-title":"A clinical trial of a whole-virus H5N1 vaccine derived from cell culture","volume":"358","author":"Ehrlich","year":"2008","journal-title":"N Engl J Med"},{"issue":"May\u2013June (9\u201310)","key":"10.1016\/j.vaccine.2009.01.116_bib22","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0264-410X(97)00301-0","article-title":"Development of a mammalian cell (Vero) derived candidate influenza virus vaccine","volume":"16","author":"Kistner","year":"1998","journal-title":"Vaccine"},{"issue":"March (17\u201319)","key":"10.1016\/j.vaccine.2009.01.116_bib23","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1016\/S0264-410X(00)00508-9","article-title":"The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines","volume":"19","author":"Pau","year":"2001","journal-title":"Vaccine"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2009.01.116_bib24","doi-asserted-by":"crossref","first-page":"5903","DOI":"10.1128\/JVI.73.7.5903-5911.1999","article-title":"A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans","volume":"73","author":"Lu","year":"1999","journal-title":"J Virol"},{"issue":"October (19)","key":"10.1016\/j.vaccine.2009.01.116_bib25","doi-asserted-by":"crossref","first-page":"12401","DOI":"10.1128\/JVI.79.19.12401-12407.2005","article-title":"Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain","volume":"79","author":"de Wit","year":"2005","journal-title":"J Virol"},{"issue":"October (5)","key":"10.1016\/j.vaccine.2009.01.116_bib26","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.coph.2007.06.004","article-title":"Preparing for a possible pandemic: influenza A\/H5N1 vaccine development","volume":"7","author":"Keitel","year":"2007","journal-title":"Curr Opin Pharmacol"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2009.01.116_bib27","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S1473-3099(04)01105-3","article-title":"Confronting the avian influenza threat: vaccine development for a potential pandemic","volume":"4","author":"Stephenson","year":"2004","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2009.01.116_bib28","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1750-2659.2007.00011.x","article-title":"Vaccines for an influenza pandemic: scientific and political challenges","volume":"1","author":"Haaheim","year":"2007","journal-title":"Influenza Other Respir Viruses"},{"issue":"October (5)","key":"10.1016\/j.vaccine.2009.01.116_bib29","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1586\/14760584.6.5.685","article-title":"Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation","volume":"6","author":"Hem","year":"2007","journal-title":"Expert Rev Vaccines"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2009.01.116_bib30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0001-706X(02)00057-8","article-title":"The 1999\u20132000 avian influenza (H7N1) epidemic in Italy: veterinary and human health implications","volume":"83","author":"Capua","year":"2002","journal-title":"Acta Trop"},{"issue":"5","key":"10.1016\/j.vaccine.2009.01.116_bib31","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s007050170128","article-title":"Changes in the haemagglutinin and the neuraminidase genes prior to the emergence of highly pathogenic H7N1 avian influenza viruses in Italy","volume":"146","author":"Banks","year":"2001","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2009.01.116_bib32","unstructured":"Major DL, Cox RJ, Smith J, Vogel F, Haaheim LR, Wood JM. Evaluation of a PER.C6 cell grown influenza H7N1 virus vaccine in BALB\/c mice. Options for the control of influenza VI. Toronto, Canada;2007."},{"key":"10.1016\/j.vaccine.2009.01.116_bib33","unstructured":"WHOIfVR. Tables on the Clinical trials of pandemic influenza prototype vaccines;2008."},{"key":"10.1016\/j.vaccine.2009.01.116_bib34","unstructured":"WHO Expert Committee on Biological Standardization. WHO biosafety risk assessment and guidelines for the production and quality control of human influenza pandemic vaccines. Annex 5. 2005 [cited 2005 24\u201328 October]; Available from: <www.who.int\/entity\/vaccine_research\/diseases\/influenza\/ECBS_2005_Annex_5_Influenza.pdf>."},{"issue":"May (9523)","key":"10.1016\/j.vaccine.2009.01.116_bib35","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0140-6736(06)68656-X","article-title":"Safety and immunogenicity of an inactivated split-virion influenza A\/Vietnam\/1194\/2004 (H5N1) vaccine: phase I randomised trial","volume":"367","author":"Bresson","year":"2006","journal-title":"Lancet"},{"issue":"August (11)","key":"10.1016\/j.vaccine.2009.01.116_bib36","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/0264-410X(94)90334-4","article-title":"An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination","volume":"12","author":"Cox","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.01.116_bib37","doi-asserted-by":"crossref","unstructured":"Eriksson J-C, Cox RJ, Szyszko E, Davidsson \u00c5, Brokstad KA. Local and systemic cytokine and chemokine responses after parenteral influenza vaccination. Influenza Other Respir Viruses 2007;1(4):139\u201346.","DOI":"10.1111\/j.1750-2659.2007.00019.x"},{"issue":"July (3)","key":"10.1016\/j.vaccine.2009.01.116_bib38","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/jmv.10408","article-title":"Sialic acid receptor specificity on erythrocytes affects detection of antibody to avian influenza haemagglutinin","volume":"70","author":"Stephenson","year":"2003","journal-title":"J Med Virol"},{"issue":"October (8)","key":"10.1016\/j.vaccine.2009.01.116_bib39","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1086\/444390","article-title":"Serological analysis of serum samples from humans exposed to avian H7 influenza viruses in Italy between 1999 and 2003","volume":"192","author":"Puzelli","year":"2005","journal-title":"J Infect Dis"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2009.01.116_bib40","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1128\/JCM.37.4.937-943.1999","article-title":"Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays","volume":"37","author":"Rowe","year":"1999","journal-title":"J Clin Microbiol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.01.116_bib41","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/infdis\/171.1.198","article-title":"Parenteral influenza vaccination induces a rapid systemic and local immune response","volume":"171","author":"Brokstad","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.01.116_bib42","unstructured":"Committee. Note for guidance on harmonization of requirements for influenza vaccines (CPMP\/BWP\/214\/96). European Agency for the Evaluation of Medicinal Products, March 12, 1997; 1996."},{"key":"10.1016\/j.vaccine.2009.01.116_bib43","first-page":"115","article-title":"Safety, reactogenicity and immunogenicity of Madin Darby Canine Kidney cell-derived inactivated influenza subunit vaccine. A meta-analysis of clinical studies","volume":"vol. 98","author":"Palache","year":"1999"},{"issue":"May (19)","key":"10.1016\/j.vaccine.2009.01.116_bib44","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1016\/j.vaccine.2008.02.068","article-title":"Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial","volume":"26","author":"Rumke","year":"2008","journal-title":"Vaccine"},{"issue":"March (5)","key":"10.1016\/j.vaccine.2009.01.116_bib45","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1086\/527489","article-title":"Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults","volume":"197","author":"Bernstein","year":"2008","journal-title":"J Infect Dis"},{"issue":"September (9540)","key":"10.1016\/j.vaccine.2009.01.116_bib46","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(06)69294-5","article-title":"Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial","volume":"368","author":"Lin","year":"2006","journal-title":"Lancet"},{"issue":"August (9587)","key":"10.1016\/j.vaccine.2009.01.116_bib47","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0140-6736(07)61297-5","article-title":"Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial","volume":"370","author":"Leroux-Roels","year":"2007","journal-title":"Lancet"},{"issue":"December (9400)","key":"10.1016\/j.vaccine.2009.01.116_bib48","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/S0140-6736(03)15014-3","article-title":"Safety and antigenicity of whole virus and subunit influenza A\/Hong Kong\/1073\/99 (H9N2) vaccine in healthy adults: phase I randomised trial","volume":"362","author":"Stephenson","year":"2003","journal-title":"Lancet"},{"issue":"July (1\u20132)","key":"10.1016\/j.vaccine.2009.01.116_bib49","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.virusres.2004.02.029","article-title":"Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use","volume":"103","author":"Hehme","year":"2004","journal-title":"Virus Res"},{"issue":"February (13\u201314)","key":"10.1016\/j.vaccine.2009.01.116_bib50","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/S0264-410X(00)00395-9","article-title":"Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans","volume":"19","author":"Treanor","year":"2001","journal-title":"Vaccine"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2009.01.116_bib51","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1542\/peds.2007-1064","article-title":"Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age","volume":"121","author":"Nolan","year":"2008","journal-title":"Pediatrics"},{"issue":"August (33)","key":"10.1016\/j.vaccine.2009.01.116_bib52","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1016\/j.vaccine.2008.05.077","article-title":"Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults","volume":"26","author":"Nolan","year":"2008","journal-title":"Vaccine"},{"issue":"November (9)","key":"10.1016\/j.vaccine.2009.01.116_bib53","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1086\/592172","article-title":"Safety and immunogenicity of an inactivated influenza A\/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: results of a phase I\u2013II randomized clinical trial","volume":"198","author":"Keitel","year":"2008","journal-title":"J Infect Dis"},{"issue":"April (8)","key":"10.1016\/j.vaccine.2009.01.116_bib54","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1086\/428948","article-title":"Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A\/Duck\/Singapore\/97 (H5N3) vaccine: a potential priming strategy","volume":"191","author":"Stephenson","year":"2005","journal-title":"J Infect Dis"},{"issue":"April (15)","key":"10.1016\/j.vaccine.2009.01.116_bib55","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0264-410X(02)00632-1","article-title":"Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A\/Duck\/Singapore\/97 vaccine in a primed human population","volume":"21","author":"Stephenson","year":"2003","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2009.01.116_bib56","doi-asserted-by":"crossref","first-page":"e1401","DOI":"10.1371\/journal.pone.0001401","article-title":"Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine","volume":"3","author":"Baras","year":"2008","journal-title":"PLoS ONE"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2009.01.116_bib57","first-page":"199","article-title":"Gross-neutralisation of antibodies elicited by an inactivated split-virion influenza A\/Vietnam\/1194\/2004 (H5N1) vaccine in healthy adults against H5N1 clade 2 strains","volume":"1","author":"H\u00f6schler","year":"2008","journal-title":"Influenza Other Respir Viruses"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.01.116_bib58","first-page":"47","article-title":"Protective measures and human antibody response during an avian influenza H7N3 outbreak in poultry in British Columbia, Canada","volume":"176","author":"Skowronski","year":"2007","journal-title":"CMAJ"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2009.01.116_bib59","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1086\/515656","article-title":"Systemic and mucosal immune responses in young children and adults after parenteral influenza vaccination","volume":"178","author":"el-Madhun","year":"1998","journal-title":"J Infect Dis"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.01.116_bib60","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1128\/JVI.01957-06","article-title":"Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines","volume":"81","author":"Sasaki","year":"2007","journal-title":"J Virol"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2009.01.116_bib61","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.4049\/jimmunol.181.5.3665","article-title":"IL-2 producing memory CD4+T lymphocytes are closely associated with the generation of IgG-secreting plasma cells","volume":"181","author":"Litjens","year":"2008","journal-title":"J Immunol"},{"issue":"August (5737)","key":"10.1016\/j.vaccine.2009.01.116_bib62","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1126\/science.1115717","article-title":"Containing pandemic influenza at the source","volume":"309","author":"Longini","year":"2005","journal-title":"Science"},{"issue":"July (7101)","key":"10.1016\/j.vaccine.2009.01.116_bib63","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nature04795","article-title":"Strategies for mitigating an influenza pandemic","volume":"442","author":"Ferguson","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2009.01.116_bib64","series-title":"The third European influenza conference","article-title":"The safety, immunogenicity and protective efficacy of a Per. C6 cell grown influenza H7N1 virus vaccine in preclincial and clinical studies","author":"Cox","year":"2008"},{"issue":"May (18)","key":"10.1016\/j.vaccine.2009.01.116_bib65","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1016\/j.vaccine.2007.01.083","article-title":"Inactivated influenza H5N1 whole-virus vaccine with aluminum adjuvant induces homologous and heterologous protective immunities against lethal challenge with highly pathogenic H5N1 avian influenza viruses in a mouse model","volume":"25","author":"Ninomiya","year":"2007","journal-title":"Vaccine"},{"issue":"October (8)","key":"10.1016\/j.vaccine.2009.01.116_bib66","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1086\/507709","article-title":"Cross-protectiveness and immunogenicity of influenza A\/Duck\/Singapore\/3\/97(H5) vaccines against infection with A\/Vietnam\/1203\/04(H5N1) virus in ferrets","volume":"194","author":"Lipatov","year":"2006","journal-title":"J Infect Dis"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2009.01.116_bib67","doi-asserted-by":"crossref","first-page":"e360","DOI":"10.1371\/journal.pmed.0030360","article-title":"Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets","volume":"3","author":"Suguitan","year":"2006","journal-title":"PLoS Med"},{"issue":"October (42)","key":"10.1016\/j.vaccine.2009.01.116_bib68","doi-asserted-by":"crossref","first-page":"5393","DOI":"10.1016\/j.vaccine.2008.07.084","article-title":"H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses","volume":"26","author":"Mahmood","year":"2008","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09001789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09001789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:46:17Z","timestamp":1633049177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09001789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":68,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0264410X09001789"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.01.116","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}